| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |